tert-Butyl ((1-(2-chloroacetyl)piperidin-3-yl)methyl)(ethyl)carbamate

Catalog No. :
ACIWAV532
CAS No. :
1353966-54-7
Molecular Formula :
C15H27ClN2O3
Molecular Weight :
318.85

IUPAC Name:tert-butyl ((1-(2-chloroacetyl)piperidin-3-yl)methyl)(ethyl)carbamate

tert-Butyl ((1-(2-chloroacetyl)piperidin-3-yl)methyl)(ethyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1288.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1-(2-chloroacetyl)piperidin-3-yl)methyl)(ethyl)carbamate
IUPAC Nametert-butyl ((1-(2-chloroacetyl)piperidin-3-yl)methyl)(ethyl)carbamate
MDL No.MFCD21094685
Molecular FormulaC15H27ClN2O3
Molecular Weight318.85
SMILESO=C(OC(C)(C)C)N(CC1CN(C(CCl)=O)CCC1)CC
InChI KeyGDXMNCWKHFDWMQ-UHFFFAOYSA-N
Synonym[1-(2-Chloro-acetyl)-piperidin-3-ylmethyl]-ethyl-carbamic acid tert-butyl ester;Carbamic acid, N-[[1-(2-chloroacetyl)-3-piperidinyl]methyl]-N-ethyl-, 1,1-dimethylethyl ester
CAS No.1353966-54-7

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H318-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIWAV532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWAV532 route product structure diagram
    ACIWAV5321353966-54-7
Inquiry

2. ACIWAV532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWAV532 route product structure diagram
    ACIWAV5321353966-54-7
Inquiry

Comments (0)